Internet-delivered Attention Training for Obsessive-Compulsive Disorder

November 11, 2014 updated by: Dr. Andrea Ertle, Humboldt-Universität zu Berlin

The goal of this study is to investigate an attention training program for participants with Obsessive-Compulsive Disorder. The attention training consists of a modified dot probe task with picture stimuli related to washing and checking paired with neutral pictures.

Participants are randomly assigned to an experimental and a placebo-control group. After a minimum of 4 weeks of attention training we expect to find differences between participants of the experimental and the control group in terms of attention bias, OCD symptoms, anxiety and depression.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

108

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Berlin, Germany, 10099
        • Humboldt-Universität zu Berlin

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • diagnosis of primary OCD according to OCI-R self report (cut-off >=18)

Exclusion Criteria:

  • suicidal
  • substance abuse or addiction
  • psychotic symptoms
  • visual impairment if not compensated with optical aid

Current treatment is not an exclusion criterion, but data on treatment status (current psycho- or pharmacotherapy for OCD) will enter our statistical analyses.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Attention Training Placebo

Same procedure, stimulus material, frequency and duration as in experimental group.

The only difference: In the placebo group the probe randomly appears at one of the two locations on the screen so as not to train attention in any direction.

Thus, the placebo training sessions are identical to the bias assessment sessions.

Experimental: Attention Training Program

The Attention Training consists of a modified dot-probe task. In this task pairs of pictures (OCD-relevant/neutral) are presented for 500 ms on a computer screen. Next, a probe appears on one of the two former picture locations. Participants have to react to that probe by pressing the corresponding button on the keyboard. One training session takes approximately 10 minutes in which 160 stimulus pairs are shown.

In the experimental group the probe always appears at the location of the neutral picture so as to train attention away from OCD-relevant stimuli.

Participants are asked to complete at least 2 training sessions per week over a period of 5 weeks. The first and last session are bias assessment sessions (see outcome measures), but participants stay blind to this.

Other Names:
  • ABMT
  • ATP
  • Attention Bias Modification Treatment
  • Bias Modification
  • Attentional Training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Yale-Brown Obsessive-Compulsive Scale Self-Report Scale (Y-BOCS-SRS) T1
Time Frame: pre-treatment, estimated: between day 1 and day 7 after enrolment (no time limit set)
The Y-BOCS-SRS measures severity of OCD symptoms.
pre-treatment, estimated: between day 1 and day 7 after enrolment (no time limit set)
Yale-Brown Obsessive-Compulsive Scale Self-Report Scale (Y-BOCS-SRS) T2
Time Frame: post-treatment, between day 1 and 6 after T2 Bias Assessment (time limit set)
The Y-BOCS-SRS measures severity of OCD symptoms.
post-treatment, between day 1 and 6 after T2 Bias Assessment (time limit set)
Yale-Brown Obsessive-Compulsive Scale Self-Report Scale (Y-BOCS-SRS) T3
Time Frame: follow-up, between day 27 and 50 after T2 questionnaires (time limit set)
The Y-BOCS-SRS measures severity of OCD symptoms.
follow-up, between day 27 and 50 after T2 questionnaires (time limit set)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Obsessive-Compulsive Inventory-Revised (OCI-R) T1
Time Frame: pre-treatment, estimated: between day 1 and day 7 after enrolment (no time limit set)
The OCI-R measures severity of OCD symptoms.
pre-treatment, estimated: between day 1 and day 7 after enrolment (no time limit set)
Obsessive-Compulsive Inventory-Revised (OCI-R) T2
Time Frame: post-treatment, between day 1 and 6 after T2 Bias Assessment (time limit set)
The OCI-R measures severity of OCD symptoms.
post-treatment, between day 1 and 6 after T2 Bias Assessment (time limit set)
Obsessive-Compulsive Inventory-Revised (OCI-R) T3
Time Frame: follow-up, between day 27 and 50 after T2 questionnaires (time limit set)
The OCI-R measures severity of OCD symptoms.
follow-up, between day 27 and 50 after T2 questionnaires (time limit set)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Beck Anxiety Inventory (BAI) T1
Time Frame: pre-treatment, estimated: between day 1 and day 7 after enrolment (no time limit set, all further steps relative to exact time point of T1 questionnaires)
The BAI measures severity of anxiety symptoms.
pre-treatment, estimated: between day 1 and day 7 after enrolment (no time limit set, all further steps relative to exact time point of T1 questionnaires)
Beck Anxiety Inventory (BAI) T2
Time Frame: post-treatment, between day 1 and 6 after T2 Bias Assessment (time limit set)
The BAI measures severity of anxiety symptoms.
post-treatment, between day 1 and 6 after T2 Bias Assessment (time limit set)
Beck Anxiety Inventory (BAI) T3
Time Frame: follow-up, between day 27 and 50 after T2 questionnaires (time limit set)
The BAI measures severity of anxiety symptoms.
follow-up, between day 27 and 50 after T2 questionnaires (time limit set)
Beck Depression Inventory II (BDI-II) T1
Time Frame: pre-treatment, estimated: between day 1 and day 7 after enrolment (no time limit set, all further steps relative to exact time point of T1 questionnaires)
The BDI measures severity of depressive symptoms.
pre-treatment, estimated: between day 1 and day 7 after enrolment (no time limit set, all further steps relative to exact time point of T1 questionnaires)
Beck Depression Inventory II (BDI-II) T2
Time Frame: post-treatment, between day 1 and 6 after T2 Bias Assessment (time limit set)
The BDI measures severity of depressive symptoms.
post-treatment, between day 1 and 6 after T2 Bias Assessment (time limit set)
Beck Depression Inventory II (BDI-II) T3
Time Frame: follow-up, between day 27 and 50 after T2 questionnaires (time limit set)
The BDI measures severity of depressive symptoms.
follow-up, between day 27 and 50 after T2 questionnaires (time limit set)
Attention bias towards OCD-relevant stimuli at T1 measured with a dot-probe task.
Time Frame: after T1 questionnaires and pre-treatment, estimated: between day 1 and 3 after T1 questionnaires (no time limit set)

Attention bias is measured using a dot-probe task. In this task pairs of pictures (OCD-relevant/neutral) are presented briefly on a computer screen. Next, a probe randomly appears on one of the two former picture locations. Participants have to react to that probe by pressing the corresponding button on the keyboard.

Attention bias is calculated as the mean difference in reaction times between trials in which the probe appears at the OCD-relevant location vs. trials in which it appears at the neutral location. The bias assessment session is masked as first training sessions in both groups.

after T1 questionnaires and pre-treatment, estimated: between day 1 and 3 after T1 questionnaires (no time limit set)
Attention bias towards OCD-relevant stimuli at T2 measured with a dot-probe task.
Time Frame: post-treatment, after a minimum of 8 training sessions over a time of 4 weeks, estimated: between day 1 and 4 after last training session (no time limit set)

Attention bias is measured using a dot-probe task. In this task pairs of pictures (OCD-relevant/neutral) are presented briefly on a computer screen. Next, a probe randomly appears on one of the two former picture locations. Participants have to react to that probe by pressing the corresponding button on the keyboard.

Attention bias is calculated as the mean difference in reaction times between trials in which the probe appears at the OCD-relevant location vs. trials in which it appears at the neutral location.

post-treatment, after a minimum of 8 training sessions over a time of 4 weeks, estimated: between day 1 and 4 after last training session (no time limit set)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2013

Primary Completion (Actual)

July 1, 2014

Study Completion (Actual)

July 1, 2014

Study Registration Dates

First Submitted

November 28, 2013

First Submitted That Met QC Criteria

December 17, 2013

First Posted (Estimate)

December 23, 2013

Study Record Updates

Last Update Posted (Estimate)

November 13, 2014

Last Update Submitted That Met QC Criteria

November 11, 2014

Last Verified

November 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obsessive-Compulsive Disorder

Clinical Trials on Attention Training Program

3
Subscribe